United States · Venture startup
6 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$172Mraised across 6 rounds since 2009, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $5.0M sold, first sale Aug 2014
Reported by finsmes.comSEC filing: $15M sold, first sale May 2011
Reported by onbiovc.comSEC filing: $22M sold, first sale May 2010
From a historical funding record
Reported by constellationpharma.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Venrock
Third Rock Ventures
The Column Group
SR One
Altitude Life Science Ventures
Altitude Life Science Ventures
GenentechMissing a round, or an investor who was in one? Tell us.
This firm lists Constellation Pharmaceuticals as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Constellation Pharmaceuticals's investors include Venrock, Third Rock Ventures, The Column Group, SR One and Altitude Life Science Ventures, and 2 more on record.
Constellation Pharmaceuticals has raised $172M across 6 rounds since 2009.
Constellation Pharmaceuticals's most recent round was a Venture of $5.0M in Aug 2014.
Constellation Pharmaceuticals's largest round on record is $95M (Series C), in Jan 2012.
Constellation Pharmaceuticals's first round on record, in Aug 2009, was backed by Venrock, Third Rock Ventures and The Column Group and 1 others.
Constellation Pharmaceuticals's latest named round is a Venture, in Aug 2014.
Constellation Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 